Evaluation of Skeletal Myoblast Transplant for Treating Ischemic Heart Failure Phase 2 Study Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Study

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-004034-41

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The coprimary objectives of this study are to assess the recovery of contractility in akinetic myocardial segments that have received transplanted skeletal myoblasts as measured by echocardiogram, and to evaluate the change in left ventricular ejection fraction (LVEF).


Critère d'inclusion

  • Ischemic Heart Failure

Liens